Pfizer Vaccine Gets FDA Nod

Pfizer Vaccine Gets FDA Nod

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

FDA advisors have voted to recommend the emergency use authorization of Pfizer's COVID-19 vaccine, stating that its benefits outweigh the risks. The vote was 17 in favor, 4 against, and 1 abstention. Michelle Cortez, a healthcare reporter, explains the significance of this decision and the expected timeline for FDA's authorization. The vaccine is anticipated to be distributed soon, but logistical challenges such as maintaining cold temperatures and setting up clinics may delay the process. Vaccinations could start by mid-week following the authorization.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was the outcome of the FDA advisors' vote regarding Pfizer's vaccine?

No decision made

Complete rejection

Unanimous approval

Majority approval with some dissent

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What age group did the FDA advisors recommend the Pfizer vaccine for?

Only seniors aged 65 and older

Only adults aged 18 and older

Everyone aged 16 and older

Children under 16

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was the main concern among some FDA advisors regarding the vaccine recommendation?

The vaccine's effectiveness

The inclusion of 16 and 17-year-olds

The manufacturing process

The cost of the vaccine

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the expected timeline for the FDA to grant emergency use authorization for the Pfizer vaccine?

No specific timeline

Within a month

By the end of the week

Sometime next year

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What logistical challenge is associated with the distribution of the Pfizer vaccine?

Lack of transportation vehicles

Shortage of medical staff

Requirement for very cold storage temperatures

Insufficient vaccine doses